A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia

C Michel Zwaan, Stefan Söderhäll, Benoit Brethon, Matteo Luciani, Carmelo Rizzari, Ronald W Stam, Emmanuelle Besse, Catherine Dutreix, Franca Fagioli, Phoenix A Ho, Carlo Dufour, Rob Pieters

Research output: Contribution to journalArticle

Original languageEnglish
Number of pages4
JournalBritish Journal of Haematology
DOIs
Publication statusE-pub ahead of print - Sep 11 2018

Cite this

Zwaan, C. M., Söderhäll, S., Brethon, B., Luciani, M., Rizzari, C., Stam, R. W., Besse, E., Dutreix, C., Fagioli, F., Ho, P. A., Dufour, C., & Pieters, R. (2018). A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.15593